A Feasibility Study of the CroíValve DUO System for Tricuspid Regurgitation - Trial NCT05296148
Access comprehensive clinical trial information for NCT05296148 through Pure Global AI's free database. This phase not specified trial is sponsored by CroiValve Limited and is currently Recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 10 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
CroiValve Limited
Timeline & Enrollment
N/A
Jun 17, 2022
Mar 31, 2025
Primary Outcome
Freedom from device or procedure related serious adverse events
Summary
This study is prospective, multicentre, non-randomized single-arm early feasibility study to
 evaluate the safety and performance of the CroíValve DUO Transcatheter Tricuspid Coaptation
 Valve System in patients with severe Tricuspid Regurgitation.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05296148
Device Trial